IL31RA and Alzheimer disease: Taken together, the evidence suggests that Se-FA reverses pathological changes in a multitude of lipid metabolites in the brains of AD mice, and SL metabolism, fatty acid metabolism, GPI-anchor biosynthesis and GPL metabolism may be involved in the improving effects of Se-FA on AD pathology.